HHS abruptly terminates funding for Atlanta biotech’s trio of next-gen vaccine studies
The U.S. government continues to end contacts related to the $5 billion Project NextGen initiative, this time terminated funding for an Atlanta biotech’s lead program that’s currently being tested in a trio of mid-stage trials.
The U.S. government continues to end contacts related to the $5 billion Project NextGen initiative, this time terminated funding for an Atlanta biotech’s lead program that’s currently being tested in a trio of mid-stage trials.
